Related Experiment Video

Updated: May 21, 2026

A Method to Study α-Synuclein Toxicity and Aggregation Using a Humanized Yeast Model
08:24

A Method to Study α-Synuclein Toxicity and Aggregation Using a Humanized Yeast Model

Published on: November 25, 2022

New therapeutic strategies for cancer and neurodegeneration emerging from yeast cell-based systems

Clara Pereira1, Mariana Leão, Joana Soares

  • 1REQUIMTE, Department of Biological Sciences, Laboratory of Microbiology, Faculty of Pharmacy, University of Porto, Portugal.

Current Pharmaceutical Design
|June 2, 2012
PubMed

Insights

Yeast cell systems accelerate the discovery of novel therapeutic agents for cancer and neurodegeneration. These systems, when combined with mammalian models, offer powerful drug screening opportunities for these complex human diseases.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pharmacology

Background:

  • Cancer and neurodegenerative diseases lack effective therapeutic strategies despite advances in understanding their molecular basis.
  • There is a significant need to accelerate the discovery of new therapeutic agents for these debilitating conditions.

Purpose of the Study:

  • To review the role of yeast cell-based systems in identifying new drugs and therapeutic targets for cancer and neurodegeneration.
  • To highlight the impact of yeast systems, particularly in early-phase research and when complemented by mammalian models.

Main Methods:

  • Review of existing evidence on yeast's contribution to drug discovery in human diseases.
  • Discussion of yeast target-based drug screening approaches utilizing genomic technologies.
  • Focus on genetic and chemical high-throughput analysis within yeast systems.

Main Results:

  • Yeast systems provide valuable contributions to the discovery of therapeutic opportunities for cancer and neurodegeneration.
  • Evidence demonstrates the successful application of yeast in identifying potential drug leads.
  • Various yeast-based screening methods are effective for high-throughput analysis.

Conclusions:

  • Yeast serves as a powerful model organism and screening system for discovering novel drug compounds.
  • Continued utilization of yeast systems, alongside complementary approaches, holds significant promise for developing new treatments for cancer and neurodegeneration.
  • This review underscores past successes and future opportunities in leveraging yeast for therapeutic advancements.

More Related Videos

Mating-based Overexpression Library Screening in Yeast11:39

Mating-based Overexpression Library Screening in Yeast

Published on: July 6, 2018

Saccharomyces cerevisiae Models of Alzheimer's Disease to Screen Genes, Mutations, and Chemicals Affecting Amyloid Beta Production by γ-Secretase11:57

Saccharomyces cerevisiae Models of Alzheimer's Disease to Screen Genes, Mutations, and Chemicals Affecting Amyloid Beta Production by γ-Secretase

Published on: June 24, 2025

Related Concept Videos

Bioreactor Controls-III01:22

Bioreactor Controls-III

Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
Yeast Signaling01:28

Yeast Signaling

Yeasts are single-celled organisms, but unlike bacteria, they are eukaryotes (cells with a nucleus). Cell signaling in yeast is similar to signaling in other eukaryotic cells. A ligand, such as a protein or a small molecule released from a yeast cell, attaches to a receptor on the cell surface. The binding stimulates second-messenger kinases to activate or inactivate transcription factors that further regulate gene expression. Many of the yeast intracellular signaling cascades have similar...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.